These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17023704)

  • 21. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats.
    Hemanth Kumar B; Dinesh Kumar B; Diwan PV
    Pharm Biol; 2017 Dec; 55(1):146-155. PubMed ID: 27677544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.
    Antoniades C; Demosthenous M; Tousoulis D; Antonopoulos AS; Vlachopoulos C; Toutouza M; Marinou K; Bakogiannis C; Mavragani K; Lazaros G; Koumallos N; Triantafyllou C; Lymperiadis D; Koutsilieris M; Stefanadis C
    Hypertension; 2011 Jul; 58(1):93-8. PubMed ID: 21518967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading.
    Wanby P; Brattström L; Brudin L; Hultberg B; Teerlink T
    Scand J Clin Lab Invest; 2003; 63(5):347-53. PubMed ID: 14599157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation.
    Labinjoh C; Newby DE; Wilkinson IB; Megson IL; MacCallum H; Melville V; Boon NA; Webb DJ
    Clin Sci (Lond); 2001 Feb; 100(2):127-35. PubMed ID: 11171280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults.
    Chao CL; Kuo TL; Lee YT
    Circulation; 2000 Feb; 101(5):485-90. PubMed ID: 10662744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
    Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM
    Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.
    Doupis J; Eleftheriadou I; Kokkinos A; Perrea D; Pavlatos S; Gonis A; Katsilambros N; Tentolouris N
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):453-8. PubMed ID: 20200816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
    Zheng H; Huang X; Zhang Q; Katz SD
    Kidney Int; 2006 Feb; 69(4):679-84. PubMed ID: 16395269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
    Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance.
    Arcaro G; Fava C; Dagradi R; Faccini G; Gaino S; Degan M; Lechi C; Lechi A; Minuz P
    J Hypertens; 2004 Apr; 22(4):775-81. PubMed ID: 15126920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.
    Engler MM; Engler MB; Malloy M; Chiu E; Besio D; Paul S; Stuehlinger M; Morrow J; Ridker P; Rifai N; Mietus-Snyder M
    Int J Clin Pharmacol Ther; 2004 Dec; 42(12):672-9. PubMed ID: 15624283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.
    Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM; Bank AJ
    Vasc Med; 2007 Nov; 12(4):311-8. PubMed ID: 18048467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplementation of a γ-tocopherol-rich mixture of tocopherols in healthy men protects against vascular endothelial dysfunction induced by postprandial hyperglycemia.
    Mah E; Noh SK; Ballard KD; Park HJ; Volek JS; Bruno RS
    J Nutr Biochem; 2013 Jan; 24(1):196-203. PubMed ID: 22841396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
    Lentz SR; Rodionov RN; Dayal S
    Atheroscler Suppl; 2003 Dec; 4(4):61-5. PubMed ID: 14664904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.